Roles of the Skp2/p27 axis in the progression of chronic nephropathy
Related Experiment Video
Updated: May 15, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Sayuri Suzuki1, Naro Ohashi, Masatoshi Kitagawa
1Department of Molecular Biology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, 431-3192, Japan.
Abstract:
S-phase kinase-associated protein 2 (Skp2) is an F-box protein component of the Skp/Cullin/F-box-type E3 ubiquitin ligase that targets several cell cycle regulatory proteins for degradation through the ubiquitin-dependent pathway. Skp2-mediated degradation of p27, a cyclin-dependent kinase inhibitor, is involved in cell cycle regulation. Tubular epithelial cell proliferation is a characteristic feature of renal damage that is apparent in the early stages of nephropathy. The p27 level is associated with the progression of renal injury, and increased Skp2 expression in progressive nephropathy is implicated in decreases of p27 expression. In Skp2(-/-) mice, renal damage caused by unilateral ureteral obstruction (UUO) was ameliorated by p27 accumulation, mainly in tubular epithelial cells. However, the amelioration of UUO-induced renal injury in Skp2(-/-) mice was prevented by p27 deficiency in Skp2(-/-)/p27(-/-) mice. These results suggest that the Skp2-mediated reduction in p27 is a pathogenic activity that occurs during the progression of nephropathy. Here, we discuss the roles of the Skp2/p27 axis and/or related signaling pathways/components in the progression of chronic nephropathy.
Insights
S-phase kinase-associated protein 2 (Skp2) promotes kidney damage by degrading p27. Inhibiting Skp2 or preserving p27 levels may protect against progressive nephropathy.
Area of Science:
- Molecular Biology
- Cell Biology
- Nephrology
Background:
- S-phase kinase-associated protein 2 (Skp2) is an F-box protein crucial for the ubiquitin-dependent degradation of cell cycle regulators.
- Skp2 targets p27, a cyclin-dependent kinase inhibitor, influencing cell cycle progression and tubular epithelial cell proliferation.
- Tubular epithelial cell proliferation is a hallmark of early nephropathy, with p27 levels correlating with renal injury progression.
Purpose of the Study:
- To investigate the role of the Skp2/p27 axis in the pathogenesis of progressive nephropathy.
- To elucidate the functional significance of Skp2-mediated p27 degradation in renal damage.
Main Methods:
- Utilized a mouse model of unilateral ureteral obstruction (UUO) to induce renal injury.
- Compared renal damage and p27 accumulation in wild-type, Skp2 knockout (Skp2(-/-)), and double knockout (Skp2(-/-)/p27(-/-)) mice.
- Assessed the impact of Skp2 and p27 deficiency on tubular epithelial cell proliferation and renal pathology post-UUO.
Main Results:
- Unilateral ureteral obstruction (UUO)-induced renal damage was ameliorated in Skp2(-/-) mice, correlating with increased p27 accumulation in tubular epithelial cells.
- The protective effect observed in Skp2(-/-) mice was abolished in Skp2(-/-)/p27(-/-) mice, indicating p27's critical role in this amelioration.
- These findings highlight Skp2-mediated p27 reduction as a pathogenic mechanism in progressive nephropathy.
Conclusions:
- The Skp2/p27 axis plays a significant role in the progression of chronic nephropathy.
- Targeting Skp2 or modulating p27 levels presents a potential therapeutic strategy for mitigating renal injury.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Nephrons
Diabetic Nephropathy
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease II: Clinical Manifestations
